NET LOSS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2026

Schedule of computation of basic and diluted net loss per ordinary share


	Six Months Ended June 30,
	2026	2025
	US$	US$
Numerator:
Net loss attributable to ordinary shareholders	(150,942)	(313,038)
Numerator for basic and diluted net loss per ordinary share calculation	(150,942)	(313,038)
Denominator:
Weighted average number of ordinary shares, basic and diluted¹	645,541,822	659,335,966
Denominator for basic and diluted net loss per ordinary share calculation	645,541,822	659,335,966
Net loss per ordinary share attributable to ordinary shareholders
—Basic and diluted	(0.23)	(0.47)

Schedule of potentially dilutive ordinary share equivalents excluded from the computation of net loss per share


		Six Months Ended June 30,
		2026		2025
Share options (i)		14,671,161		14,561,421
2025 Convertible Notes (ii) (note 14)		65,250,704		86,583,567
2026 Convertible Notes (iii) (note 14)		109,972,857		—
ATW Convertible Notes (iv) (note 14)		5,921,401		—
Meritz put option (v)		—		32,500,000
Public Warrant (vi) (note 12)		9,054,522		9,054,522
Sponsor Warrant (vi) (note 12)		5,486,784		5,486,784
Total		210,357,429		148,186,294

(i)For the six months ended June 30, 2026 and 2025, 14,671,161 and 14,561,421 vested and unvested share options are not included in the calculation of diluted loss per share as their exercise price was above underlying stock price.

(ii)Represents the number of potentially dilutive ordinary shares equivalent on as-if-converted basis, calculated by the principal and accrued interest of US$70,000 divided by the estimated fair value of ordinary shares as of June 30, 2026, which are not included in the calculation of diluted loss per share due to their antidilutive effect.

(iii)Represents the number of potentially dilutive ordinary shares equivalent on as-if-converted basis, calculated by the principal and accrued interest of US$128,325 divided by the estimated fair value of ordinary shares as of June 30, 2026, which are not included in the calculation of diluted loss per share due to their antidilutive effect.

(iv)Represents the number of potentially dilutive ordinary shares equivalent on as-if-converted basis, calculated by the principal and accrued interest of US$6,838 divided by the average closing market price of ordinary shares, which was not included in the calculation of diluted loss per share due to their antidilutive effect.

(v)For the six months ended June 30, 2025, the exercise of put option issued to Meritz are not included in the calculation of diluted loss per share due to antidilutive effect using reverse treasury stock method.

(vi)For the six months ended June 30, 2026 and 2025, public and sponsor warrants are not included in the calculation of diluted loss per share as their exercise price is above underlying stock price.